Skip to search formSkip to main contentSkip to account menu

MG 262

Known as: MG-262, MG262, boro-LLL 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Boronic Acids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Inhibition of Candida species via Proteosome Inhibitor MG-262 (ZL3B)
  • 2017
  • Corpus ID: 44522800
Backround: Candida species take the fourth place among the microorganisms which cause hospital infections. New therapeutic agents… 
2015
2015
Gene expression profiling of CD133-positive cells in coronary artery disease.
Gene expression profiles of CD133-positive cells from patients with coronary artery disease (CAD) were analyzed to identify key… 
2014
2014
P01.19A GENOME-WIDE RNAI SYNTHETIC LETHAL SCREEN FOR SENSITIZERS OF GLIOBLASTOMA MULTIFORME TO TEMOZOLOMIDE.
Glioblastoma multiforme (GBM) is highly resistant to therapy and carries a dismal prognosis. Standard of care includes surgery… 
Review
2013
Review
2013
Myeloma-Induced Osteocyte Death Was Blunted By Proteasome Inhibitors Through The Modulation Of Autophagy
Osteocytes are critical in the maintenance of bone integrity regulating bone remodeling through the cell death and autophagy, a… 
2013
2013
Effects of Proteasome inhibitors on chondrogenesis and Linear bone growth
Linear bone growth occurs at the growth plate, a thin layer of cartilage between the epiphysis and metaphysis of long bones. In… 
Review
2012
Review
2012
Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients
Abstract 3978 Multiple myeloma (MM) is characterized by a severe unbalanced and uncoupling bone remodeling leading to osteolysis… 
2008
2008
[Effect of extracellular signal regulated kinase signal pathway on apoptosis induced by MG262 in ovarian cancer cells].
OBJECTIVE To investigate whether the proteasomes inhibitor MG262 exerts its anti-cancer function by inducing apoptosis in human… 
2004
2004
Proteasome inhibition enhances HLA-class-II antibody-dependent polymorphonuclear cell mediated cytotoxicity against B-cell lymphoma
Monoclonal antibodies (mAb) complemented the therapy of malignant lymphomas. Currently, mAb against CD20 or CD52 are approved and… 
Highly Cited
2002
Highly Cited
2002
Proteasome inhibitors stimulate activator protein‐1 pathway via reactive oxygen species production
2001
2001
Role of the Proteasome in the Regulation of Fetal Fibronectin Secretion in Human Placenta
The goal of the current study was to examine the role of the ubiquitin‐proteasome system (UPS), a pathway of intracellular… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)